Clinical Education InitiativeMenu
Search
Home > Courses > Update on Hypogonadism in Aging HIV-infected Men

Update on Hypogonadism in Aging HIV-infected Men

Update on Hypogonadism in Aging HIV-infected Men
Update on Hypogonadism in Aging HIV-infected Men
Play
Sorry, this learning module is not available for mobile devices.
Resource ID: CM359
Original Presentation: 11/11/2014
Web Posting: 3/30/2015
CE Expiration: 11/11/2017
Presenter
  • Todd T. Brown, MD, PhD
    Associate Professor of Medicine
    Johns Hopkins University
Learning Objectives
At the completion of this educational session, participants will:
  1. Understand the optimal screening recommendations regarding hypogonadism and the current controversies.
  2. Be aware of the potential risks and benefits of testosterone therapy, particularly with respect to the older male.
Presenter Bio
Todd Brown, MD, PhD
Dr. Brown is an Professor of Medicine and Epidemiology in the Division of Endocrinology, Diabetes, & Metabolism at Johns Hopkins University where he is also the primary endocrine consultant to the Johns Hopkins HIV Clinic. He is a graduate of Columbia University College of Physicians and Surgeons and the Johns Hopkins Bloomberg School of Public Health. He completed his clinical training at Georgetown University and Johns Hopkins. His research focuses on metabolic, endocrine, and skeletal abnormalities observed in HIV-infected patients, particularly as related to aging. He is a co-investigator in the Multicenter AIDS Cohort Study and the AIDS Clinical Trial Group. In the MACS, he is the Chair of the Metabolic Working Group. In the ACTG, he serves in leadership positions on multiple studies.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on November 11, 2014 and will terminate November, 2017.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length. 

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity. 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose. 
  • Dr. Brown (Presenter) had the following personal financial relationships in the prior 12 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to Abbott/AbbVie. Dr. Brown supported his presentation and clinical recommendations with the best available evidence from the medical literature, and submitted his slides in advance for adequate peer review.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

PRN Learning Modules